Table 1 Clinicopathological characteristics of considered PDAC, PanNET and AVC
Variable | PDAC (n = 55) | PanNET (n = 42) | AVC (n = 19)b |
|---|---|---|---|
Gender | |||
 F | 22 (40%) | 16 (38%) | 10 (53%) |
 M | 33 (60%) | 26 (62%) | 9 (47%) |
 Age (years) | 64.5 ± 10,5 | 51.1 ± 13.65 | 63.4 ± 11.18 |
(median 67.0) | (median 49.5) | (median 63) | |
Primary tumor | |||
 T1 | 5 (9%) | 20 (47%) | 3 (15%) |
 T2 | 25 (46%) | 15 (36%) | 6 (30%) |
 T3 | 9 (16%) | 7 (17%) | 9 (45%) |
 T4 | 6 (11%) | 0 (0%) | 0 (0%) |
an.a. | 10 (18%) | 0 (0%) | 1 (5%) |
Regional lymph nodes | |||
 N0 | 3 (6%) | 22 (52%) | 7 (35%) |
 N1 | 15 (27%) | 12 (29%) | 7 (35%) |
 N2 | 21 (38%) | 0 (0%) | 4 (20%) |
 n.a. | 16 (29%) | 8 (19%) | 1 (5%) |
Distant metastasis | |||
 M0 | 38 (69%) | 40 (95%) | 18 (90%) |
 M1 | 11 (20%) | 2 (5%) | 1 (10%) |
 n.a. | 6 (11%) | 0 (0%) | 0 (0%) |
Clinical stage | |||
 I | 3 (6%) | 11 (26%) | 6 (30%) |
 II | 15 (27%) | 11 (26%) | 0 (0%) |
 III | 20 (36%) | 10 (24%) | 12 (60%) |
 IV | 11 (20%) | 2 (5%) | 1 (5%) |
 n.a. | 6 (11%) | 8 (19%) | 0 (0%) |
Grade | |||
 G1 | 0 (0%) | 29 (69%) | 2 (10%) |
 G2 | 25 (45.5%) | 13 (31%) | 12 (60%) |
 G3 | 14 (25.5%) | 0 (0%) | 4 (20%) |
 n.a. | 16 (29%) | 0 (0%) | 1 (5%) |
Lymphovascular invasion | |||
 absent | 1 (2%) | 17 (40.5%) | 3 (15%) |
 present | 38 (69%) | 17 (40.5%) | 15 (75%) |
 n.a. | 16 (29%) | 8 (19%) | 1 (5%) |
Perineural invasion | |||
 absent | 0 (0%) | 22 (52%) | 5 (25%) |
 present | 39 (71%) | 12 (29%) | 13 (65%) |
 n.a. | 16 (29%) | 8 (19%) | 1 (5%) |